AzTrials
AzTrials

MyopiaNCT05017376

Evaluating the Effect of Optical Zones on Correction for SMILE: Vector Analysis

An observational study of Myopia, run by Tianjin Eye Hospital at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Evaluate the effect of the size of optical zones (OZ) on myopia and astigmatism correction in small incision lenticular extraction. Read more about this study

Who is it for?
Ages 18 to 45 years
Conditions the study is for
Myopia
What is being tested?
small incision lenticular extraction
Type of treatment
Surgery or procedure
How many people
140 participants
Where
1 siteChina
Study dates
1 Aug 2020to 1 Aug 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: age of patients between 18-45 years; spherical refraction of -3.00 to -6.00 diopters (D) with or without astigmatism (<-3.00 D); spherical equivalent, -3.00 to -6.00 D; corrected distant visual acuity (CDVA), >20/25

Who may be able to join

  • no ocular conditions
  • normal topography
  • central corneal thickness, >500µm
  • residual stromal thickness, >280 µm
  • pupil diameter, 2.78-4.9 mm (average, 3.76±0.43 mm);

Who cannot join

  • history of intraocular surgery
  • pupil diameter, >4.9 mm or <2.78mm
  • keratoconus or corneal ectasia

Trial locations and contacts

1 site in 1 country.

China1 site
  • Tianjin Eye Hospital

    Tianjin

Other trials in China

About this study

Official title: Evaluating the Effect of Optical Zones on Myopia and Astigmatism Correction in SMILE: Vector Analysis

Evaluate the effect of the size of optical zones (OZ) on myopia and astigmatism correction in small incision lenticular extraction.

Read the detailed description

To retrospectively study whether different surgical optical zone sizes affect the correction of diopter and astigmatism in myopia patients. Divided into 2 groups according to the diameter of the optical zone. The vector analysis method was used to analyze the changes and errors of astigmatism in TR and SIR after operation. Generalized Estimation Equation (GEE) model is used for multiple regression analysis to evaluate the potential factors related to the error value.

Conditions
Myopia
Being tested
small incision lenticular extraction
Keywords
small incision lenticule extraction, vector analysis
Medical subject headings
Myopia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • small incision lenticular extractionProcedure or surgery

    In patients with the same degree of myopia, different optical zones were designed for operation

Study groups in NCT05017376
Study groupRoleWhat they receive
group Asmall optical zone
Receives: Procedure: small incision lenticular extraction
group Blarge optical zone
Receives: Procedure: small incision lenticular extraction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. astigmatic changes

    Observe the effect on changes in astigmatism by target induced astigmatism (TIA) versus surgically induced astigmatism (SIA)

    Measured: 2021.03

  2. error value

    Target refraction (TR) and surgically induced refraction (SIR) under different optical zones

    Measured: 2021.04

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Aug 2021
  2. Study start1 Aug 2020
  3. Primary completion31 Dec 2020
  4. Study completion1 Aug 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
140 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05017376
Sponsor's protocol ID
TJYYLL-202034
Status last verified
Aug 2021
First submitted
11 Aug 2021
Last updated
23 Aug 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Moshirfar M, Thomson AC, West WB Jr, Hall MN, McCabe SE, Thomson RJ, Ronquillo YC, Hoopes PC. Initial Single-Site Experience Using SMILE for the Treatment of Astigmatism in Myopic Eyes and Comparison of Astigmatic Outcomes with Existing Literature. Clin Ophthalmol. 2020 Oct 29;14:3551-3562. doi: 10.2147/OPTH.S276899. eCollection 2020.

    PubMed 33154614
  • Dishler JG, Slade S, Seifert S, Schallhorn SC. Small-Incision Lenticule Extraction (SMILE) for the Correction of Myopia with Astigmatism: Outcomes of the United States Food and Drug Administration Premarket Approval Clinical Trial. Ophthalmology. 2020 Aug;127(8):1020-1034. doi: 10.1016/j.ophtha.2020.01.010. Epub 2020 Jan 15.

    PubMed 32173114

Questions about this trial

What is this clinical trial studying?

An observational study of Myopia, run by Tianjin Eye Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

astigmatic changes (time frame: 2021.03). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05017376, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Aug 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in